Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning

Area of Science:

• Cardiology
• Diabetology
• Cardioprotection

Background:

• Ischemic heart disease (IHD) poses a high mortality risk, especially with co-existing diabetes mellitus (DM).
• Myocardial infarct size is a critical prognostic factor in IHD.
• Current therapies are insufficient, necessitating novel cardioprotective strategies.

Purpose of the Study:

• To review the impact of DM on myocardial infarct size.
• To examine the effects of DM on ischemic preconditioning (PC) and postconditioning (PostC).
• To discuss strategies for protecting the diabetic heart during ischemia/reperfusion.

Main Methods:

• Literature review of studies investigating DM, IHD, and cardioprotection.
• Analysis of experimental and clinical data on infarct size and conditioning effects in diabetic models.
• Synthesis of findings to identify discrepancies and future research directions.

Main Results:

• DM significantly alters myocardial response to ischemia/reperfusion injury.
• The efficacy of ischemic PC and PostC may be diminished in the presence of DM.
• Pharmacological agents successful in animal models often fail in clinical trials, potentially due to comorbidities like DM.

Conclusions:

• Diabetes mellitus presents unique challenges in managing IHD and limiting infarct size.
• Understanding DM-specific mechanisms of cardioprotection is crucial for developing effective therapies.
• Future research should focus on tailored strategies to protect the diabetic heart.